AE

Alan L. Epstein

UC University Of Southern California: 24 patents #14 of 1,826Top 1%
Northwestern University: 2 patents #821 of 3,846Top 25%
📍 Los Angeles, CA: #198 of 12,377 inventorsTop 2%
🗺 California: #13,801 of 386,348 inventorsTop 4%
Overall (All Time): #96,157 of 4,157,543Top 3%
35
Patents All Time

Issued Patents All Time

Showing 1–25 of 35 patents

Patent #TitleCo-InventorsDate
12258421 Humanized anti-nuclear antibodies for targeting necrosis in cancer therapy Peisheng Hu 2025-03-25
11667715 Lym-1 and Lym-2 antibody compositions and improved car constructs Peisheng Hu, Long Zheng 2023-06-06
11384157 Humanized anti-nuclear antibodies for targeting necrosis in cancer therapy Peisheng Hu 2022-07-12
11136401 Car t-cell therapy directed to LHR for the treatment of solid tumors Peisheng Hu, Jacek Pinski 2021-10-05
10961317 CD20 scFv-ELPs methods and therapeutics John Andrew MacKay, Peisheng Hu, Suhaas Aluri 2021-03-30
10711064 Lym-1 and Lym-2 targeted CAR cell immunotherapy 2020-07-14
10196435 OX40L fusion protein for the immunotherapy of tumors of veterinary animals Peisheng Hu, John R. Ohlfest 2019-02-05
9746480 Human myeloid derived suppressor cell cancer markers Melissa G. Lechner 2017-08-29
9522958 Cancer targeted innate immunity Leslie A. Khawli 2016-12-20
8883497 Human myeloid derived suppressor cell cancer markers Melissa G. Lechner 2014-11-11
8795672 Compositions and methods for cancer immunotherapy Jiali Li, Peisheng Hu 2014-08-05
8545838 Compositions and methods for cancer immunotherapy Jiali Li, Peisheng Hu 2013-10-01
8268788 Combination cancer immunotherapy with co-stimulatory molecules Peishing Hu 2012-09-18
8207130 Combination cancer immunotherapy with co-stimulatory molecules Peishing Hu 2012-06-26
8124066 Methods of using interleukin-2 mutants with reduced toxicity Peisheng Hu 2012-02-28
7803361 Therapeutic use of interleukin-2 mutants Peisheng Hu 2010-09-28
7696175 Combination cancer immunotherapy with co-stimulatory molecules Peishing Hu 2010-04-13
7514073 Therapeutic use of interleukin-2 mutants Peisheng Hu 2009-04-07
7371371 Interleukin-2 mutants with reduced toxicity Peisheng Hu 2008-05-13
6737064 Method for the diagnosis of neoplastic tissue comprising administering a vasopermeability enhancing peptide of human interleukin-2 Leslie A. Khawli 2004-05-18
6696276 Vasopermeability-enhancing conjugates Michael Glovsky 2004-02-24
6524823 Vasopermeability-enhancing conjugates Michael Glovsky 2003-02-25
6403096 Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof Leslie A. Khawli 2002-06-11
6274343 Vasopermeability enhancing immunoconjugates Michael Glovsky 2001-08-14
6071491 Detection of necrotic malignant tissue and associated therapy Clive R. Taylor 2000-06-06